1995
DOI: 10.1177/000456329503200601
|View full text |Cite
|
Sign up to set email alerts
|

Testing for Haemochromatosis in the Diabetic Clinic

Abstract: SUMMARY.Random serum transferrin saturation (TS) was measured in 1194 patients attending a diabetic clinic. Twenty-one patients had TS> 55070 and in three of these patients repeat random TS was < 55070. Seventeen patients were recalled for fasting serum TS and ferritin measurement. Ten patients had fasting TS> 55%. The diagnosis of haemochromatosis was confirmed by liver biopsy in a total of six patients, three of whom were previously unsuspected. Haemochromatosis was the possible diagnosis in a further four p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 28 publications
0
13
0
Order By: Relevance
“…I Trials were also excluded if some other screening test (for example, serum iron) was used,":" if diagnostic testing was not routinely available for individuals with positive screening results," " or if the screened population consisted largely of blood donors":" or was not truly population based. [19][20][21][22][23] ·Trial protocol included a third sample with the same criteria for interpretation as sample 2.…”
Section: Trlals From the Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…I Trials were also excluded if some other screening test (for example, serum iron) was used,":" if diagnostic testing was not routinely available for individuals with positive screening results," " or if the screened population consisted largely of blood donors":" or was not truly population based. [19][20][21][22][23] ·Trial protocol included a third sample with the same criteria for interpretation as sample 2.…”
Section: Trlals From the Analysismentioning
confidence: 99%
“…Others focus on screening individuals who are not representative of the general population, such as hospitalised patients, diabetics, or blood donors. [14][15][16][17][18][19][20][21][22][23] Blood donors with the homozygous genotype, by being phlebotomised, are actually receiving treatment for their condition, so it is not surprising that clinical manifestations are less frequent. I 4-18 Intervention trials have used differing cut off levels for the screening tests and often do not account for subjects who fail to complete the diagnostic studies, or subjects homozygous for haemochrornatosis whose measurements fall below the screening cut off level.…”
mentioning
confidence: 99%
“…In a screening study of patients with liver disease, who presumably are more likely to have HHC, the positive predictive value of a single elevated transferrin saturation test was 41 percent (65). In patients with diabetes, the positive predictive value of repeated elevated transferrin saturation tests ranged from 63 to 83 percent when HHC was defined as increased liver iron stores (58,66,67).…”
Section: Laboratory Tests Transferrin Saturation and Serum Ferritinmentioning
confidence: 99%
“…The treatment is safe and acceptable and in some countries the blood collected from venesection treatment is utilized by the blood transfusion services. Screening of the general population, 24 particular sub-groups of the population 25,26 and relatives of an index case have been advocated, 1 but so far only the latter is widely accepted.…”
Section: Screeningmentioning
confidence: 99%
“…40 Although proving statistical signi®cance is dif®cult, there is a de®nite trend to increased haemochromatosis rates in this population with prevalence rates between 1 in 100 and 1 in 200 con®rmed by liver biopsy. 25 Arthralgia is the second commonest feature of haemochromatosis at presentation. 35 One study has examined the prevalence of haemochromatosis in a rheumatology clinic 26 and found the highest prevalence of previously unrecognized haemochromatosis, at 1.5 in 100 cases, of any screened population.…”
Section: Population Sub-group Screeningmentioning
confidence: 99%